The Convergence Guide:  Life Sciences in New England provides a detailed look at the life sciences industry in New England, including biotech, medical device, and pharma activity, regional partnerships, policy issues, and university research initiatives.  This special edition includes a detailed analysis of New England's most influential venture capital firms, stem cell research initiatives, promising early-stage life sciences companies, large medical device employers, and pharma companies with outposts in the region. It also includes interviews with executives such as Genzyme CEO Henri Termeer, Rib-X Pharmaceuticals CEO Susan Froshauer, venture capitalist Jonathan Fleming, and MIT researcher Robert Langer.  Written by seasoned journalists and featured industry experts, The Convergence Guide delivers an unbiased perspective on the trends and issues that impact the growth of the life sciences in New England . This 64-page, softbound edition will be a valuable resource -- and an enlightening read. Order your copy of this special softbound edition of The Guide for $195.

2006 Edition